BioAge Labs (BIOA) Net Cash Flow (2023 - 2026)
BioAge Labs (BIOA) posted Net Cash Flow of $52.9 million for Q1 2026, up 298.44% sequentially from -$26.7 million in Q4 2025, and up 154.64% YoY from $20.8 million in Q1 2025.
BioAge Labs (BIOA) Net Cash Flow (2023 - 2026) Analysis & Trends
BioAge Labs has reported Net Cash Flow for 4 years, with the latest figure at $52.9 million in Q1 2026.
- Quarterly Net Cash Flow rose 154.64% year-over-year to $52.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$15.6 million (down 119.48% YoY) and the FY2025 annual result came in at -$165.4 million, down 150.22% from the prior year.
- Net Cash Flow improved to $52.9 million in Q1 2026 per BIOA's latest filing, from -$26.7 million in the prior quarter.
- Over five years, Net Cash Flow peaked at $175.4 million in Q3 2024 and troughed at -$96.9 million in Q1 2025.
- A 4-year average of $20.7 million and a median of -$7.1 million in 2023 frame the typical range for Net Cash Flow.
- The sharpest annual moves came in 2024 and 2025: Net Cash Flow surged 307.51% in 2024, then tumbled 235.1% in 2025.
- Over 4 years, Net Cash Flow stood at -$9.5 million in 2023, then surged by 307.51% to $19.7 million in 2024, then sank by 235.1% to -$26.7 million in 2025, then jumped by 298.44% to $52.9 million in 2026.
- According to Business Quant data, Net Cash Flow over the past three periods registered $52.9 million, -$26.7 million, and -$4.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | -81.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | -458.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -881.03 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 523.50 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -912.40 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 64.40 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 93.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | BioAge Labs | 427.31 Mn | 427.31 Mn | -14.23 Mn | -167.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -167.81 Mn |
| Jun 30, 2026 | -167.81 Mn |
| Mar 31, 2026 | 52.92 Mn |
| Mar 31, 2026 | 52.92 Mn |
| Dec 31, 2025 | -26.67 Mn |
| Dec 31, 2025 | -26.67 Mn |
| Sep 30, 2025 | -4.75 Mn |
| Sep 30, 2025 | -4.75 Mn |
| Jun 30, 2025 | -37.11 Mn |
| Jun 30, 2025 | -37.11 Mn |
| Mar 31, 2025 | -96.85 Mn |
| Mar 31, 2025 | -96.85 Mn |
| Dec 31, 2024 | 19.74 Mn |
| Dec 31, 2024 | 19.74 Mn |
| Sep 30, 2024 | 175.45 Mn |
| Sep 30, 2024 | 175.45 Mn |
| Jun 30, 2024 | -18.20 Mn |
| Jun 30, 2024 | -18.20 Mn |
| Mar 31, 2024 | 152.33 Mn |
| Mar 31, 2024 | 152.33 Mn |